Zolmitriptan
- TRADE NAME: Zomig (AstraZeneca)
- INDICATIONS: Migraine attacks
- CLASS: 5-HT1 agonist, Serotonin receptor agonist, Triptan
- HALF-LIFE: 3 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cimetidine, Ciprofloxacin, Dihydroergotamine, Ergot-containing drugs, Fluoxetine, Fluvoxamine, Isocarboxazid, Levofloxacin, MAO inhibitors, Methysergide, Moclobemide, Moxifloxacin, Naratriptan, Norfloxacin, Ofloxacin, Oral Contraceptives, Phenelzine, Propranolol, Rizatriptan, Sertraline, Sibutramine, SNRIs, SSRIs, St John's Wort, Sumatriptan, Tranylcypromine
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
